Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Hatoon Ezzat, MD, Matthew C Cheung, MD, SM, Lisa K Hicks, MD, MSc, Kevin C Murphy, MD, Chantal S Leger, MD, Linda R Taggart, MD, Jordana Boro, Julio SG Montaner, MD, Marianne Harris, MD, Linda M Vickars, MD, Heather A Leitch, MD, PhD

Blood (2008) 112 (11): 2587.

https://doi.org/10.1182/blood.V112.11.2587.2587

Published: 2008

Journal Articles

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Heather A. Leitch, MD, PhD, Hatoon Ezzat, MD, Meaghan D. Rollins, BHK, Dominic H.C. Wong, Chantal S. Leger, MD, Khaled M. Ramadan, MD, Michael J. Barnett, MB, Linda M. Vickars, MD

Blood (2007) 110 (11): 4653.

https://doi.org/10.1182/blood.V110.11.4653.4653

Published: 2007

Journal Articles

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Hatoon Ezzat, MD, Douglas Filipinko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4666.

https://doi.org/10.1182/blood.V108.11.4666.4666

Published: 2006

Journal Articles

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

Hatoon Ezzat, MD, Jonathan C. Wong, BHSc, Douglas Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4667.

https://doi.org/10.1182/blood.V108.11.4667.4667

Published: 2006

Journal Articles

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Hatoon Ezzat, MD, J. Doug Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio Montaner, MD, Marianne Harris, MD, Robert Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4674.

https://doi.org/10.1182/blood.V106.11.4674.4674

Published: 2005

NARROW

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only